Teva Pharmaceuticals USA Inc recalls Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc.,
Recalled June 8, 2022 · FDA recall D-0992-2022 · Teva Pharmaceuticals USA
Hazard
Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing. · FDA Class I
Units
4224 cartons
Sold at
Distributed Nationwide in the USA
Description
Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.
Product
Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC 0172-5241-60.
Manufacturer(s)
Teva Pharmaceuticals USA Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →